News for hackers. Stuff that matters.

A comment on Biohackers take aim at big pharma’s stranglehold on insulin. Parent comment

Re:Biohackers take aim at big pharma’s stranglehold on insulin by erosenbe0 on Monday June 28, 2021 @11:34PM (#27671455)
What IP though? Humalog is off patent. It now appears to be just red-tape or collusiom.
[ Parent | on HN ]
Re:Biohackers take aim at big pharma’s stranglehold on insulin by AstralStorm on Wednesday June 30, 2021 @02:36AM (#27685617)
The problem is that patent system is a joke, and the description is likely broken (or incomplete) enough so that even a bunch of experts will have to experiment with the process to decrypt it.

You really need to buy out trade secrets of this particular brand.

[ Parent | on HN ]